Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
## Development Roadmap ## eSpraye plans to enter the clinic in 2026 with a Phase 1/2 study assessing safety, PK, and early FVC trends
SIRT1 mediates the effect of GLP-1 receptor agonist exenatide on ameliorating hepatic steatosis
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (dis CoVeRy): a phase 3, randomised, controlled, open-label trial
Familiarize yourself with proper injection techniques if self-administering at home
US$ 22.47
US$ 29.73
US$ 27.89
US$ 22.45
US$ 19.99
